Page last updated: 2024-09-03

bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) and Cancer of Ovary

bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) has been researched along with Cancer of Ovary in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davidson, R; Feig, B; Hu, W; Khokhar, AR; Kumagai, S; Lee, SJ; Maclean, DS; Mansfield, P; Siddik, ZH; Verschraegen, CF1
al-Baker, S; Han, I; Khokhar, AR; Ling, YH; Perez-Soler, R1
Han, I; Khokhar, AR; Perez-Soler, R1
Hong, WK; Huber, M; Khokhar, AR; Lee, SJ; Murphy, WK; Perez-Soler, R; Shin, DM; Siddik, ZH1

Trials

2 trial(s) available for bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) and Cancer of Ovary

ArticleYear
Phase I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato( trans- R, R-1, 2-diaminocyclohexane)-platinum II entrapped in multilamellar liposome vesicles.
    Journal of cancer research and clinical oncology, 2003, Volume: 129, Issue:10

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Area Under Curve; Ascites; Carcinoma, Signet Ring Cell; Colorectal Neoplasms; Endometrial Stromal Tumors; Female; Humans; Injections, Intraperitoneal; Liposomes; Male; Mesothelioma; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Peritoneum; Radionuclide Imaging; Technetium; Tissue Distribution

2003
Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Drug Carriers; Female; Humans; Liposomes; Lung Neoplasms; Male; Mesothelioma; Metabolic Clearance Rate; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Pleura; Pleural Effusion, Malignant; Pleural Neoplasms; Rats

1997

Other Studies

2 other study(ies) available for bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) and Cancer of Ovary

ArticleYear
Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells.
    Cancer research, 1993, Oct-15, Volume: 53, Issue:20

    Topics: Antineoplastic Agents; Biological Transport; Cell Survival; Cisplatin; Dimyristoylphosphatidylcholine; DNA, Neoplasm; Drug Carriers; Drug Resistance; Female; Humans; Kinetics; Liposomes; Organoplatinum Compounds; Ovarian Neoplasms; Phosphatidylglycerols; Platinum; Spectrophotometry, Atomic; Tumor Cells, Cultured

1993
Intraliposomal conversion of lipophilic cis-bis-carboxylato-trans-R,R-1,2-diaminocyclohexane-platinum (II) complexes into cis-bis-dichloro-trans-R,R-1,2-diaminocyclohexane-platinum (II).
    Cancer chemotherapy and pharmacology, 1996, Volume: 39, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Cisplatin; Drug Carriers; Drug Stability; Female; Humans; Hydrogen-Ion Concentration; Leukemia L1210; Liposomes; Magnetic Resonance Spectroscopy; Mice; Organoplatinum Compounds; Ovarian Neoplasms; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured

1996